| Financial Year |
March 31 2023 |
| Monetary Funds |
1,064,353,898.14 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
26,151,619.93 |
| Accounts Receivable |
370,682,522.92 |
| Advances to Suppliers |
13,281,172.43 |
| Other Receivables |
26,940,435.77 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
385,280,546.21 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
123,691,559.41 |
| Other Current Assets |
31,462,034.51 |
| Total Current Assets |
2,064,771,990.27 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
589,522,253.71 |
| Under-construction Projects |
118,222,386.61 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
114,526,496.85 |
| R&D expenses |
89,415.43 |
| Goodwill |
153,824,467.84 |
| Long-Term Deferred and Prepaid Expenses |
10,282,598.98 |
| Deferred Income Tax Assets |
8,406,555.07 |
| Other Non-Current Assets |
436,718,233.75 |
| Sub-Total of Non-Current Assets |
1,784,033,327.79 |
| Total Assets |
3,848,805,318.06 |
| Short-Term Loans |
382,594,248.76 |
| Trading Financial liabilities |
503,851.47 |
| Notes Payable |
33,562,328.67 |
| Accounts Payable |
132,167,057.52 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
26,966,826.53 |
| Taxes Payable |
27,904,646.89 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
85,201,888.50 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
53,038,995.81 |
| Other Current Liabilities |
21,229,184.71 |
| Sub-Total of Current Liabilities |
805,292,970.62 |
| Long-term Loans |
51,610,165.15 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
43,947,192.16 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
291,739,440.05 |
| Total Liabilities |
1,097,032,410.67 |
| Paid-In Capital(Or Share Stock) |
816,206,041.00 |
| Capital Surplus |
1,230,443,192.23 |
| Surplus Reserve |
76,713,150.34 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
517,624,773.44 |
| Minority Stockholder's Interest |
100,808,418.04 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,650,964,489.35 |
| Owner's Equity（Stockholder's Equity） |
2,751,772,907.39 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,848,805,318.06 |
